|

(Biomedical Science),

Interface) Medical
Biotechnology

cell organ system

I Allied Medical Science

1|Page
 DNA Cellular/Tissue/Genetic Engineering

Genetic
Engineering) Organ Transplantation
Rehabilitation

(Biohazards)

2|Page
 |

Diagnostic use of medical

Instrument.
Perform Medical Research

Help Procurement and Purchase

Committee/ Personnel to estimate
and bye medical accessories.)

3|Page
 MBBS COURSE (BMDC

Curriculum

18. -
a)
b)
c)
d)

4|Page
 Prof. R. J. GARST)
NITOR)

NICVD) NINS)

ev

5|Page


6|Page
 BASIC

(http://www.dghs.gov.bd/index.php/en/medical-biotechnology/87-english-root/medical-
biotechnology/499-medical-biotechnology-program-of-hpnsdp-2011-16-of-bangladesh-health-
ministry)

Medical biotechnology program of HPNSDP 2011-16 of Bangladesh Health Ministry-

The Bangladesh government has undertaken a program on medical biotechnology
through its 5-year long Health, Population & Nutrition Sector Development Program
2011-16 (HPNSDP 2011-16) of the Ministry of Health & Family Welfare. This
program is called "Medical Biotechnology (MBT) and is included in the Operational
Plan "Health Information System & e-Health" of DGHS.

Background
The government has taken policy decisions for rapid deployment of medical
biotechnology, to confront countrys future health, nutrition and livelihood
challenges.
The government constituted a National Taskforce on Biotechnology with Honorable
Prime Minister as chair and adopted National Biotechnology Policy and several
sector-specific National Biotechnology Guidelines including National Guidelines on
Medical Biotechnology.

7|Page
 The later has been published as government gazette and spells out MOHFWs
deliverables in next 25 years. In HPNSDP 2011-16, the medical biotechnology has
been included as a regular program of the Ministry of Health & Family Welfare.
5-year (2011-16) MBT implementation plan:

Short and medium term

1. Establishment of Center for Medical Biotechnology;
2. Situation analysis and development of medical biotechnology plan;
3. Human resource development through sensitization/orientation
training/workshops, updating medical curriculum with focus on medical
biotechnology, improving medical biotechnology resources in medical libraries,
introducing postgraduate and technologist courses, identifying and training
career group for medical biotechnology gradually, orientation of the core group
members and concerned officials on medical biotechnology;
4. Institutional capacity building through development of lab facilities, clinical
services and epidemiological surveillance for medical biotechnology;
5. Creating R&D environment through supporting related research projects,
opening Department of Medical Biotechnology in the National Institute of
Biotechnology, establishment of a Center of Excellence for medical biotechnology,
and appropriate communication programs with potential entrepreneurs of
medical biotechnology; and
6. Creation of public awareness and regulatory system through conducting
appropriate public awareness programs, and developing and enforcing
standards, codes of practice and regulatory framework for medical
biotechnology.
Long term
Conditions will be created to attain following long term ( Year 2030+) MBT goals:
1. Medical biotechnology initiatives and infrastructures at globally competitive
level;
2. Medical biotechnology industries, laboratories and services capable to compete
globally and keep pace with global development trends;
3. Production of high quality medical biotechnology products and services for local
market as well as for export to the global market; and
4. A world-class higher education and research base to serve the rapidly growing
medical biotechnology needs both in home and in abroad.

8|Page